Across different modalitiesincluding caloric restriction, exercise-based interventions, pharmacological agents, and bariatric surgeryweight reduction has been shown to result in bone loss, reduced BMD, and compromised bone quality
Intestinal blockage: Warning labels for semaglutide drugs Ozempic and Wegovy dont warn about intestinal blockage though users have reported the condition in post-marketing experiences
For now, at least two lawmakers Tommy Tuberville (R-Ala.) and Diana Harshbarger (R-Tenn.) have issued letters asking the FDA to limit enforcement action against certain peptides, including BPC-157
Clinical Evidence: Semaglutide and Cardiovascular Blood Pressure Outcomes The SUSTAIN-6 trial, which followed over 3,000 patients with type 2 diabetes, documented that weekly semaglutide reduced the risk of major adverse cardiovascular events by 26% compared to placebo